[HTML][HTML] Assessment of hypercholesterolemia prevalence and its demographic variations in the Republic of Kazakhstan

M Kulimbet, K Davletov, T Saliev, D Davletov… - Scientific Reports, 2024 - nature.com
Hypercholesterolemia is a major risk factor for cardiovascular disease, the leading cause of
death in Kazakhstan. Understanding its prevalence is vital for effective public health …

[HTML][HTML] Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021

J Khanali, E Ghasemi, MM Rashidi, N Ahmadi… - Scientific Reports, 2023 - nature.com
The study aimed to estimate the prevalence of lipid abnormalities in Iranian adults by
demographic characterization, geographical distribution, and associated risk factors using …

[HTML][HTML] Prevalence, awareness, treatment and control of dyslipidemia in older persons in urban and rural population in the Astana region, Kazakhstan

A Supiyev, T Nurgozhin, Z Zhumadilov, A Peasey… - BMC Public Health, 2017 - Springer
Background Despite high cardiovascular mortality in Central Asian republics of the former
Soviet Union, there is limited information about major risk factors, including blood lipids. We …

The epidemiological investigation of hyperlipidemia in the northern Henan Province

X Lu, Z Lin, J Yang - medRxiv, 2023 - medrxiv.org
Background/purpose: Hyperlipidemia is a kind of diseases with the characteristic of high
level of blood lipids, it could directly result in several serious diseases including …

[HTML][HTML] The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey

J Al-Zahrani, MM Shubair, S Al-Ghamdi… - BMC Cardiovascular …, 2021 - Springer
Background Hypercholesterolemia (HC) is an important precursor to many cardiovascular,
cerebrovascular, and peripheral vascular diseases. A report conducted by the American …

The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016

Z Aryan, N Mahmoudi, A Sheidaei, S Rezaei… - Journal of clinical …, 2018 - Elsevier
Background Hypercholesterolemia is one of the modifiable risk factors for atherosclerosis
and cardiovascular diseases. Prevention and treatment of hypercholesterolemia and other …

Assessing the effect of socioeconomic factors on prevalence of Dyslipidemia among Iranian adult population; district level analysis from 2016 STEPS national study …

H Soleimani, E Ghasemi, S Saeedi Moghaddam… - Journal of Diabetes & …, 2022 - Springer
Abstract Background Atherosclerotic Cardiovascular Disease (CVD) is the leading cause of
death globally and dyslipidemia plays a critical role in the development of this condition …

Hypercholesterolemia and its associated risk factors—Kingdom of Saudi Arabia, 2013

M Basulaiman, C El Bcheraoui, M Tuffaha… - Annals of …, 2014 - Elsevier
Purpose To assess the prevalence of hypercholesterolemia and its associated factors in the
Kingdom of Saudi Arabia. Methods A national multistage representative sample of Saudis …

[HTML][HTML] Epidemiology and Prevalence of Dyslipidemia Among Adult Population of Tehran: The Tehran Cohort Study

A Shafiee, S Kazemian, A Jalali… - Archives of Iranian …, 2024 - ncbi.nlm.nih.gov
Background: Dyslipidemia is among the leading risk factors for cardiovascular diseases
(CVDs), with an increasing global burden, especially in developing countries. We …

[HTML][HTML] The prevalence of dyslipidemia among Jordanians

M Abujbara, A Batieha, Y Khader, H Jaddou… - Journal of …, 2018 - hindawi.com
Background. Dyslipidemia is one of the major modifiable risk factors for the development of
cardiovascular disease and type two diabetes mellitus. Knowing the current prevalence of …